{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:45:18Z","timestamp":1785548718714,"version":"3.56.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Matrix extracellular phosphoglycoprotein (MEPE) was proposed as a candidate for the phosphaturic hormone phosphatonin. We found that a synthetic peptide fragment of MEPE containing the RGD and SGDG sequence stimulated new bone formation in vitro and in vivo.<\/jats:p>\n               <jats:p>Introduction: Matrix extracellular phosphoglycoprotein (MEPE) was recently identified as a candidate for the phosphaturic hormone phosphatonin, which has been implicated in disturbed phosphate metabolism, rickets, and osteomalacia associated with X-linked hypophosphatemic rickets (XLH) and oncogenic hypophosphatemic osteomalacia (OHO). MEPE expression was predominantly found in osteoblasts, and mice deficient in a homolog of MEPE showed increased bone density, suggesting that MEPE produced in osteoblasts negatively regulates bone formation. In this study, we examined the effects of a synthetic 23mer peptide fragment of MEPE (AC-100, region 242\u2013264) containing the RGD (integrin-binding) and SGDG (glycosaminoglycan-attachment) motif on bone formation in vitro and in vivo.<\/jats:p>\n               <jats:p>Materials and Methods: The osteogenic activity of AC-100 was examined in organ cultures of neonatal mouse calvariae and in vivo by injecting AC-100 onto the calvariae of mice.<\/jats:p>\n               <jats:p>Results: Histomorphometric examination showed that AC-100 stimulated new bone formation with increased numbers of osteoblasts in neonatal mouse calvariae in organ culture. In contrast, synthetic MEPE fragment peptides without either the RGD or SGDG motif failed to increase new bone formation. Repeated daily subcutaneous injections of AC-100 onto the calvariae in mice increased bone thickness and stimulated new bone formation as determined by the calcein double-labeling technique. However, peptides in which the RGD or SGDG sequence was scrambled did not stimulate new bone formation in vivo. AC-100 increased cell proliferation and alkaline phosphatase activity and activated focal adhesion kinase (FAK) and extracellular signal-regulated protein kinase (ERK) in human primary osteoblasts.<\/jats:p>\n               <jats:p>Conclusion: Our results show that a synthetic peptide corresponding with the sequence of human MEPE fragment stimulates new bone formation with increased number of osteoblasts. The results also suggest that the RGD and SGDG motifs are critical to the osteogenic activity of AC-100, presumably through activating integrin signaling pathways in osteoblasts. The anabolic effects of AC-100 may be beneficial for bone diseases associated with decreased bone formation.<\/jats:p>","DOI":"10.1359\/jbmr.0301263","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T07:01:13Z","timestamp":1146121273000},"page":"455-462","source":"Crossref","is-referenced-by-count":57,"title":["A Synthetic Peptide Fragment of Human MEPE Stimulates New Bone Formation In Vitro and In Vivo"],"prefix":"10.1093","volume":"19","author":[{"given":"Tetsuyuki","family":"Hayashibara","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Graduate School of Dentistry, Osaka University, Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Hiraga","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Graduate School of Dentistry, Osaka University, Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yi","sequence":"additional","affiliation":[{"name":"Endocrine Research, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyoshi","family":"Nomizu","sequence":"additional","affiliation":[{"name":"Division of Bioscience, Laboratory of Bio-Material Chemistry, Graduate School of Environmental Earth Science, Hokkaido University, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinari","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Acologix, Inc., Emeryville, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riko","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Graduate School of Dentistry, Osaka University, Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Endocrine Research, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"},{"name":"Department of Biochemistry, Graduate School of Dentistry, Osaka University, Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024013019213120900_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S8756-3282(00)00334-3","article-title":"Tumor-induced osteomalacia and the regulation of phosphate homeostasis","volume":"27","author":"Kumar","year":"2000","journal-title":"Bone"},{"key":"2024013019213120900_bib2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/jcem.86.2.7302","article-title":"Pathophysiology of X-linked hypophosphatemia, tumor-induced osteomalacia, and autosomal dominant hypophosphatemia: A perPHEXing problem","volume":"86","author":"Quarles","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019213120900_bib3","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1073\/pnas.111154898","article-title":"FGF23, hypophosphatemia, and rickets: Has phosphatonin been found?","volume":"98","author":"Strewler","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024013019213120900_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets","volume":"11","author":"The HYP Consortium","year":"1995","journal-title":"Nat Genet"},{"key":"2024013019213120900_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/geno.2000.6235","article-title":"MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia","volume":"67","author":"Rowe","year":"2000","journal-title":"Genomics"},{"key":"2024013019213120900_bib6","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1074\/jbc.M203250200","article-title":"Targeted disruption of the osteoblast\/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass","volume":"278","author":"Gowen","year":"2003","journal-title":"J Biol Chem"},{"key":"2024013019213120900_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/geno.2001.6553","article-title":"MEPE, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone","volume":"74","author":"Argiro","year":"2001","journal-title":"Genomics"},{"key":"2024013019213120900_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/ndt\/14.2.333","article-title":"X-linked hypophosphataemia: A homologous disorder in humans and mice","volume":"14","author":"Tenenhouse","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"2024013019213120900_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/bj20030287","article-title":"Human recombinant PHEX has a strict S1\u2032 specificity for acidic residues and cleaves peptides derived from FGF-23 and MEPE","volume":"373","author":"Campos","year":"2003","journal-title":"Biochem J"},{"key":"2024013019213120900_bib10","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","article-title":"Integrin signaling","volume":"285","author":"Giancotti","year":"1999","journal-title":"Science"},{"key":"2024013019213120900_bib11","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1073\/pnas.84.10.3194","article-title":"Identification and synthesis of a recognition signal for the attachment of glycosaminoglycans to proteins","volume":"84","author":"Bourdon","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024013019213120900_bib12","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1210\/endo.139.7.6115","article-title":"5-lipoxygenese metabolites inhibit bone formation in vitro","volume":"139","author":"Traianedes","year":"1998","journal-title":"Endocrinology"},{"key":"2024013019213120900_bib13","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in vitro and in rodents by statins","volume":"286","author":"Mundy","year":"1999","journal-title":"Science"},{"key":"2024013019213120900_bib14","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/jbmr.5650051013","article-title":"In vivo effects of human recombinant transforming growth factor \u03b2 on bone turnover in normal mice","volume":"5","author":"Marcelli","year":"1990","journal-title":"J Bone Miner Res"},{"key":"2024013019213120900_bib15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1359\/jbmr.1999.14.6.953","article-title":"Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats","volume":"14","author":"Dunstan","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024013019213120900_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1359\/jbmr.1998.13.5.777","article-title":"Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells","volume":"13","author":"Nishimura","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2024013019213120900_bib17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0142-9612(01)00145-4","article-title":"Function of linear and cyclic RGD-containing peptides in osteoprogenitor cells adhesion process","volume":"23","author":"Verrier","year":"2002","journal-title":"Biomaterials"},{"key":"2024013019213120900_bib18","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.289.5484.1501","article-title":"The osteoblast: A sophisticated fibroblast under central surveillance","volume":"289","author":"Ducy","year":"2000","journal-title":"Science"},{"key":"2024013019213120900_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/geno.1996.0421","article-title":"cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone","volume":"36","author":"Du","year":"1996","journal-title":"Genomics"},{"key":"2024013019213120900_bib20","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1359\/jbmr.1997.12.7.1009","article-title":"Cloning and sequencing of human PEX from a bone cDNA library: Evidence for its development stage-specific regulation in osteoblasts","volume":"12","author":"Guo","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024013019213120900_bib21","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1359\/jbmr.2000.15.8.1440","article-title":"Developmental expression and tissue distribution of Phex protein: Effect of the Hyp mutation and relationship to bone markers","volume":"15","author":"Ruchon","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024013019213120900_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/002215549804600405","article-title":"Pex mRNA is localized in developing mouse osteoblasts and odontoblasts","volume":"46","author":"Ruchon","year":"1998","journal-title":"J Histochem Cytochem"},{"key":"2024013019213120900_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S8756-3282(99)00106-4","article-title":"Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling","volume":"25","author":"Damsky","year":"1999","journal-title":"Bone"},{"key":"2024013019213120900_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jbmr.5650090208","article-title":"Synthetic peptide containing Arg-Gly-Asp inhibits bone formation and resorption in a mineralizing organ culture system of fetal rat parietal bones","volume":"9","author":"Gronowicz","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2024013019213120900_bib25","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1210\/endo.136.7.7540546","article-title":"Engagement of the osteoclast integrin \u03b1v\u03b23 by osteopontin stimulates phosphatidylinositol3-hydoxyl kinase activity","volume":"136","author":"Hruska","year":"1995","journal-title":"Endocrinology"},{"key":"2024013019213120900_bib26","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1359\/jbmr.2002.17.12.2130","article-title":"RGD peptides immobilized on a mechanically deformable surface promote osteoblast differentiation","volume":"17","author":"Cavalcant-Adam","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024013019213120900_bib27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0024-3205(97)00558-4","article-title":"The effects of acid glycosaminoglycans on neonatal calvarian cultures\u2014a role of keratan sulfate in Morquio syndrome?","volume":"61","author":"Fang-Kircher","year":"1997","journal-title":"Life Sci"},{"key":"2024013019213120900_bib28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1083\/jcb.107.2.743","article-title":"Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation","volume":"107","author":"Saksela","year":"1988","journal-title":"J Cell Biol"},{"key":"2024013019213120900_bib29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jcp.1041280317","article-title":"Heparin protects basic and acidic FGF from inactivation","volume":"128","author":"Gospodarowicz","year":"1986","journal-title":"J Cell Physiol"},{"key":"2024013019213120900_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M","article-title":"FGFs, heparan sulfate and FGFRs: Complex interactions essential for development","volume":"22","author":"Ornitz","year":"2000","journal-title":"Bioessays"},{"key":"2024013019213120900_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1097-4652(199810)177:1<187::AID-JCP19>3.0.CO;2-A","article-title":"Glycosaminoglycans bind granulocyte-macrophage colony stimulating factor and modulate its mitogenic activity and signaling in human osteoblastic cells","volume":"177","author":"Modrowski","year":"1998","journal-title":"J Cell Physiol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2FJBMR.0301263","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/19\/3\/455\/56473932\/5650190314.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/19\/3\/455\/56473932\/5650190314.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:06:19Z","timestamp":1710342379000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/19\/3\/455-462\/7592729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,1]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[2004,3,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.0301263","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2004,3,1]]},"published":{"date-parts":[[2004,3,1]]}}}